-
Targeted Sequencing Xenturion
Study
EGAS00001006697
-
Whole Exome Sequencing of Schizophrenia cases and controls performed at the Broad Institute on a cohort from Bristol, UK
Study
EGAS00001006274
-
Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple negative breast cancer: phase 2 adaptive BELLINI trial. WES
Study
EGAS50000000568
-
resistance mechanims to targeted therapies from DNA sequencing
Study
EGAS50000000486
-
Whole exome sequencing of prDLBCL
Study
EGAS50000000403
-
Whole-Exome Sequencing Plasma Control Samples for Benchmarking
Study
EGAS50000000565